baber/WOPTO huggingface dataset:
Patent NZ-286175-A (NZ)
Title: Laminated stretch fabric for undergarments
Inventor: GIRARD PATRICK
IPC: D06M17/00
Filed: 1996-03-13
Abstract: A fabric laminate (10) comprises first and second stretch fabrics (11 and 12) having an intermediate adhesive securement layer (13) between them. The adhesive securement layer (13) is in the form of a regularly repeating pattern which comprises an array of aligned adhesive elements (14) arranged in successive generally horizontally and vertically extending rows. The array of adhesive elements (14) is capable of offering resistance to elongation as the laminate (10) is subjected to distortion, with the pattern having a differential elongation characterised as offering different magnitudes of resistance to elongation when the fabric laminate (10) is subjected to distortion in selected different directions. The adhesive securement layer (13) is predeterminedly oriented in accordance with its differential elongation and the stretch characteristics of the fabrics (11, 12) such that the resistance to elongation offered by the laminate (10) is determined by the pattern and orientation of the individual adhesive elements (14) in conjunction with the stretch characteristics of the fabrics (11, 12). The laminate (10) may be employed to reinforce items of clothing, particularly underwear and the like. <IMAGE>
Patent NZ-294919-A (NZ)
Title: Method for testing immune competency of individual; determining total plasma/serum thiols for individual from blood sample
Inventor: PERO RONALD W
IPC: C12Q1/48
Filed: 1995-10-18
Abstract: A method of testing the immune competency of an individual by determining, from a sample of the blood of the individual, a value for total plasma/serum thiols including both protein thiols and nonprotein thiols, and comparing the value so determined with a reference value of total plasma/serum thiols to ascertain whether the determined value is higher or lower than the reference value, a determined value lower than the reference value being indicative of impaired immune function.
Patent NZ-305338-A (NZ)
Title: Vapour barrier for use in the heat insulation of buildings
Inventor: KUNZEL HARTWIG
IPC: E04D13/16
Filed: 1996-04-18
Abstract: The invention relates to a vapour barrier for use in the heat insulation of buildings, especially for use in new buildings and the renovation of old ones. The vapour barrier of the invention can effect water vapour exchange in various environmental conditions. This is accomplished by the use as the essential material of a material having a water vapour diffusion resistance depending on the environmental humidity and also had adequate tensile and tear strength.
Patent NZ-330219-A (NZ)
Title: A fungicidal composition containing phosphorus acid having a pH less than 4
Inventor: MAYNARD NIGEL PAUL
IPC: A01N43/52
Filed: 1998-04-17
Abstract: A biocidal composition being in the form of (i) a solution carried by a liquid selected from the group consisting of water and polar solvents, or (ii) as a solids mix soluble in a liquid solvent selected from the group consisting of water and polar solvents, said composition having a source of free phosphate ions selected from the group comprising phosphorous acid and phosphite compounds capable of releasing phosphite ions at a pH of below 4 and at least one biocide selected from the group comprising benzimidazoles, precursors of benzimidazoles, substituted morpholimes, organic chelate complexes of metals, precursors of such organic complexes of metals and metal ions selected Al, Co, Cu, Mn, Mo, Ni, W, V and Zn.
Patent NZ-331989-A (NZ)
Title: Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis
Inventor: CARSON DENNIS A
IPC: A61K38/00
Filed: 1997-02-20
Abstract: Method for the production of a vaccine composition useful in inducing T-cell mediated immune protection in a host against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis.  Each vaccine composition provides antigenic dnaJp1 peptide (by including the peptide or a polynucleotide, which encodes the peptide) and, optionally, other peptide fragments of the microbial dnaJ protein and/or human homologs thereof.  Also described is a method for the screening of candidates by: (i)	measuring cellular and humoral immune responses to an arthritogenic peptide (ii)	detecting the rheumatoid arthritis susceptibility sequence in the individual's HLA DR antigens
Patent NZ-334438-A (NZ)
Title: (S)-7-[(4,4'-bipiperidrin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetic acid hydrochloride as a platelet aggregation inhibitor
Inventor: ROSS STEPHEN TOREY
IPC: C07D401/14
Filed: 1997-08-29
Abstract: (S)-7-[(4,4'-bipiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetic acid hydrochloride has a melting point of 291 C and a negative specific rotation of 175.  The compound can be used in medicaments for inhibiting platelet aggregation, and specifically, to treat myocardial infarction, thrombosis, embolism, stroke and infarct-related disorders, or restenosis following angioplasty.
Patent NZ-337666-A (NZ)
Title: Stable particle in liquid formulations
Inventor: KAMPINGA JAAP
IPC: A61K38/18
Filed: 1998-03-18
Abstract: A stable particle in liquid formulation comprising a discontinuous phase of microparticles suspended in a continuous phase which is a non-aqueous liquid in which the microparticles are insoluble.  The microparticles comprise finely powdered sugar glass holding at least one biomolecular product.  The biomolecular product in the sugar glass is either in stable solid solution or by itself in suspension in the sugar glass.
Patent NZ-500887-A (NZ)
Title: Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific process
Inventor: DIXON RICHARD A
IPC: C12N5/10
Filed: 1998-05-14
Abstract: A nucleic acid molecule which encodes a lipid transfer protein wherein the encoded lipid transfer protein exhibits a SAR signal transducing property.  The nucleic acid molecule is obtained by the steps of: a) growing wild type and T-DNA transformed plants and observing for disease symptoms; b) isolating SAR mutants showing disease symptoms; c) performing SAR competence tests to validate the SAR mutation in the SAR mutants, wherein the SAR is comprised in a SAR mutant plant upon first being treated on one leaf of the plant with an avirulent inoculum and later being treated on other leaves if the plant with virulent inoculum as compared to a wild type plant which exhibits SAR upon first being treated on one leaf with an avirulent inoculum and later being treated on other leaves with a virulent inoculum; d) testing the SAR mutants to determine the position of the mutant gene in relation to the point of salicylic acid action in the signal transduction pathway, wherein the SAR mutants which are first sprayed with substance that mimics salicylic acid and acts at about the same point as salicylic acid in the SAR signal transduction pathway, challenged with a virulent inoculum, and then remain symptomless exhibit a SAR mutant gene upstream of the point of salicylic acid action in the signal transduction pathway; e) isolating DNA from those plants which are homozygous for SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action alone the signal transduction pathway; and f) probing the DNA to isolate cDNA.
Patent NZ-502508-A (NZ)
Title: Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
Inventor: ZELLER MARTIN
IPC: A01P13/00
Filed: 1998-08-04
Abstract: Pesticidally active compounds of general formula (I) where n is a number zero or one; R1 is C1-C12alkyl that is unsubstituted or may be substituted by C1-C4alkoxy, C1-C4alkylthio, C1-C4alkylsulfonyl, C3-C8cycloalkyl, cyano, C1-C6alkoxycarbonyl, C3-C6alkenyloxycarbonyl or by C3-C6alkynyloxycarbonyl; C3-C8cycloalkyl; C2-C12alkenyl; C2-C12alkynyl; C1-C12haloalkyl; or a group NR11R12 where R11 and R12 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra- or penta-methylene; R2 and R3 are each independently of the other hydrogen; C1-C8alkyl; C1-C8alkyl substituted by hydroxy, C1-C4alkoxy, mercapto or by C1-C4alkylthio; C3-C8alkenyl; C3-C8alkynyl; C3-C8cycloalkyl; C3-C8cycloalkyl-C1-C4alkyl; or the two groups R2 and R3 together with the carbon atom to which they are bonded form a three- to eight-membered ring; R4, R5, R6 and R7 are identical or different and are each independently of the others hydrogen or C1-C4alkyl; R8 is C1-C6alkyl, C3-C6alkenyl or C3-C6alkynyl; A is C1-C6alkylene; and B is optionally mono- or poly-nuclear, unsubstituted or substituted aryl; optionally mono- or poly-nuclear, unsubstituted or substituted heteroaryl; C4-C12alkyl; or C3-C8cycloalkyl. The compounds have plant-protecting properties and are suitable for protecting plants against infestation by phytopathogenic microorganisms.
Patent NZ-515202-A (NZ)
Title: Method for detecting and killing epithelial cancer cells
Inventor: BERNAL SAMUEL D
IPC: A61K45/00
Filed: 2001-02-27
Abstract: A cationic supravital mitochondrial marking agent such as toluidine blue O or rhodamine 123 is used to kill epithelial cancer cells. A diagnostic method for in vivo detection of cancerous epithelia cells by selectively marking of the mitochondria thereof comprises topically delivering to the epithelium a cationic supravital mitochondrial marking agent other than toluidine blue O and detecting the retention of the agent by the mitochondria of cancerous and precancerous cells on the epithelium.
Patent NZ-515230-A (NZ)
Title: Fast-dispersing dosage forms containing fish gelatin
Inventor: MURRAY OWEN
IPC: A61K47/42
Filed: 2000-04-07
Abstract: A pharmaceutical composition in a solid fast-dispersing dosage form comprising a carrier and an active ingredient, wherein said carrier is non-gelling fish gelatin, said form is prepared by subliming solvent from an admixture in the solid state, in which the admixture comprises the active ingredient, the carrier and the solvent, and said dosage form releases the active ingredient rapidly on contact with fluid. Also described is a process for its preparation.
Patent NZ-515599-A (NZ)
Title: A pipe connector where the longitudinal axis of outlet is parallel to the faceplate plane
Inventor: BYRNE KEVIN FRANCIS
IPC: F16L43/00
Filed: 2001-11-20
Abstract: A pipe connector having a fluid passageway with a bend between a predetermined fixed inlet and outlet. A faceplate is used for fixing the fluid passageway to a surface wherein the longitudinal axis of the outlet is substantially parallel to the plane of said faceplate.
Patent NZ-519409-A (NZ)
Title: Plastic electric fence standard with multiple longitudinal flanges and transverse ground engaging flange
Inventor: QUINN GRANT WAYNE
IPC: E04H17/08
Filed: 2002-06-07
Abstract: A fence post for supporting the multiple conductors of an electric fence includes an upper wire support part 1a with four or more flanges 2, 2a, 3, 3a coextending along the exterior of the post, and a lower tapered spike 1b to be inserted in the ground.  The flanges have apertures or slots for supporting the wires strung between the posts.  A transverse flange 5 projects around the post between the upper portion and the tapered portion.  The post can be made of a high-density polyethylene.
Patent NZ-519667-A (NZ)
Title: A putative 23kDa lipoprotein from Mycobacterium paratuberculosis and its use in Johne's disease
Inventor: MURRAY ALAN
IPC: A61K39/00
Filed: 2002-06-19
Abstract: A polypeptide comprises an amino acid sequence of SEQ ID NO:1, the sequence is obtainable from Mycobacterium avium subspecies paratuberculosis. Also disclosed are polynucleotides comprising the sequence of SEQ ID NO:2, vectors, antibodies, host cells and vaccine and diagnostic compositions. Methods of detecting Johne's disease in non-human animals or samples use the polypeptide, polynucleotide or antibodies. Also disclosed are methods for preventing or treating a non-human animal, preferably sheep, against Johne's disease comprising administrating the polypeptide to produce a protective immunological response.
Patent NZ-520174-A (NZ)
Title: Automatically operable safety shield system for syringes
Inventor: SHAW DEREK JOSEPH
IPC: A61M5/32
Filed: 2001-02-13
Abstract: An automatically operable safety shield system for use with a syringe comprises: an inner holder into which said syringe may be inserted, an outer shield mounted outwards from the inner holder axially movable between retracted and extended positions a spring positioned between said inner holder and outer shield urging said outer shield to its extended position. The inner holder ha at least one opening distally thereto, at least one first indentation and said outer shield having at least one stop member engageable with said first indentation when said outer shield is in said extended position, the outer shield may be released from its retracted position by action of a trigger positioned within said inner holder or by a protrusion on the syringe plunger.
Patent NZ-520734-A (NZ)
Title: Table assembly
Inventor: GEORGE RHYS
IPC: A47B13/08
Filed: 2002-08-12
Abstract: A table assembly having a table setting conveyor with at least one table setting support surface. The table conveyer is adapted to convey a table setting around the periphery of the table surface. A seating conveyor including at least one seating support surface which is adapted to convey at least one seating means around the base of the table assembly both driven by one or more drive means which allows both the table setting surface and the seating surface to be moved adjacently.
Patent NZ-521814-A (NZ)
Title: Method for supply of starter cultures having a consistent quality
Inventor: KRINGELUM BORGE
IPC: C12N1/20
Filed: 2001-03-17
Abstract: A method of producing a starter culture comprising the steps of: (i) supplying a stock inoculum material comprising a concentrate of starter culture organism cells such as a lactic acid bacterial species, Bifidobacterium, Propionibacterium, Staphylococcus, Micrococcus, Bacillus, Enterobacteriaceae, Actinomycetes, Corynebacterium, Brevibacterium, Pediococcusm, Pseudomonas, Sphingomonas, Mycobacterium, Rhodoccocus; (ii) directly inoculating a cultivation medium with a subset of said stock inoculum material comprising a concentrate of starter culture organism cells; (iii) propagating said starter culture organism cells in said cultivation medium for a period of time sufficient to produce a desired amount of said cells; and (iv) harvesting the propagated cells to provide a starter culture. The starter culture may be used for the inoculation of milk which is further processed to obtain a dairy product.
Patent NZ-522953-A (NZ)
Title: Tablet containing valsartan, microcrystalline cellulose, crospovidone, colloidal anhydrous silica/colloidal silicon dioxide and magnesium stearate
Inventor: GANTER SABINA MARIA
IPC: A61P43/00
Filed: 2001-06-20
Abstract: Disclosed is a tablet with a core weight of 95.0mg, comprising (per unit): (i) granulation components consisting of: 20.0 mg Valsartan 62.0 mg Microcrystalline Cellulose 10.0 mg Crospovidone 0.5 mg Colloidal Anhydrous Silica/Colloidal Silicon Dioxide 1.0 mg Magnesium Stearate and: (ii) blending components consisting essentially of : 0.5 mg Colloidal Anhydrous Silica/Colloidal Silicon Dioxide 1.0 mg Magnesium Stearate
Patent NZ-532366-A (NZ)
Title: Crystallline and amorphous forms of 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt
Inventor: FLANAGAN MARK EDWARD
IPC: A61P11/06
Filed: 2002-11-25
Abstract: Amorphous and crystallline forms of 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt, useful as inhibitors of protein kinases, and their methods of preparation are disclosed.
Patent NZ-534113-A (NZ)
Title: An excavating tool
Inventor: HORTON LEE A
Filed: 2004-07-15
Abstract: An excavating tool for pivotal attachment about an axis to the outboard end of the dipperstick of an excavating system, the tool having multiple shanks offset longitudinally of the axis and offset radially about the axis. The tool does not have a bucket configuration. The shanks are arranged on the axis so the, as the tool is rotated about the axis, the shanks engage the substrate serially and axially offset.
Patent NZ-534263-A (NZ)
Title: Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
Inventor: TUSZYNSKI MARK H
IPC: A61P25/28
Filed: 2002-12-30
Abstract: The use of a therapeutic nervous system growth factor for the manufacture of a medicament for stimulating growth or activity among cortical neurons through binding to trkB receptors, is disclosed. The amelioration of the defect, disease or damage referred to above may cause an improvement in cognitive function in the treated subject. The growth factor may be brain derived neurotrophic factor (BDNF), NT-4/5, NT-3, NGF or recombinant protein delivered by in situ expression of the growth factor from a recombinant expression vector. The subject may be a human suffering form Alzheimer's disease, and the disease ameliorated by stimulation of growth neurons in the EC.
Patent NZ-542807-A (NZ)
Title: Refrigeration system with two evaporators and a method for operating such system
Inventor: ANERSSON BENNY
IPC: F25B5/00
Filed: 2004-04-07
Abstract: This disclosure relates to a refrigeration system comprising one compressor (10) that via a closed circuit containing a circulating refrigerant is connected to a condenser (14, 14a) and two or more evaporators (21, 28). The circuit comprises a container (19, 19a) or the like communicating with the condenser (14, 14a) and has at least a first outlet communicating with at least one evaporator (21) via a first valve (22, 22a). The container (19, 19a) is arranged to receive and temporarily store a container (19, 19a) is arranged to receive and temporarily store a certain volume of the refrigerant flowing from the condenser. The container (19, 19a) is also provided with at least a second outlet (26, 26a) communicating with one or several of the additional evaporators (28) to circulate the remaining part of the refrigerant through the at least one of the last mentioned evaporators (28) when said volume has been stored in the container (19, 19a), said second outlet (26, 26a) being positioned above said first outlet.
Patent NZ-543006-A (NZ)
Title: Substituted quinobenzoxazine analogs
Inventor: WHITTEN JEFFERY P
IPC: C07D491/04
Filed: 2004-04-07
Abstract: Disclosed is a compound of formula 1 or a pharmaceutically acceptable salt thereof wherein the substituents are disclosed within the specification. Also disclosed is the use of an effective amount of the above compound or a pharmaceutical composition thereof in the manufacture for ameliorating a cell proliferative disorder such as cancer.
Patent NZ-546405-A (NZ)
Title: Dry powder inhaler
Inventor: OLSSON MAGNUS
IPC: B29C71/00
Filed: 2004-10-04
Abstract: A process for reducing electrostatic charges from one or more inhaler components, or a complete inhaler, optionally filled with a powder formulation, is disclosed. This process results in the removal of any electrostatic charge from the inhaler thereby improving the performance of the inhaler in drug delivery. The process comprises the steps of: i) placing one or more inhaler components, or a complete inhaler, optionally filled with a powder formulation in a chamber, ii) reducing the pressure of gas in the chamber, iii) returning the pressure to atmospheric pressure, and iv) optionally repeating steps ii) and iii).
Patent NZ-548105-A (NZ)
Title: Treatment of sheep to reduce flystrike using clamp with opposing elongate jaws
Filed: 2006-06-23
Abstract: A method of treating the breech region of a sheep (10), the method comprising: providing a clamp (12, 14) having opposite elongate jaws (18); applying the clamp (12, 14) to a fold of skin (20) in the breech region with a clamping force between the elongate jaws (18) sufficient to substantially starve the fold of skin (20) of blood supply; maintaining the clamp (12, 14) in place until the fold of skin (20) atrophies.
Patent NZ-549370-A (NZ)
Title: Field-shaping shielding for radio frequency identification (RFID) system
Inventor: LIEFFORT SETH A
IPC: H01Q7/00
Filed: 2005-01-07
Abstract: A radio frequency identification (RFID) system is disclosed that utilizes a substantially-contiguous conductive shield to shape an electromagnetic field formed by an antenna for communication with RFID tags. The antenna and the conductive shield have substantially planar forms, and may be mounted to a surface of a check-in / check-out area. The conductive shield is positioned around the antenna and within a plane parallel to the antenna, e.g., within the same plane. The conductive shield shapes the electromagnetic field to extend substantially in a direction perpendicular to the antenna, and prevents the electromagnetic field from forming substantially over the conductive shield.
Patent NZ-556259-A (NZ)
Title: Digital image collector for x-ray systems
Inventor: CASEAULT JEAN
IPC: C09J7/02
Filed: 2005-11-29
Abstract: A digital image capturer for receiving X-rays and providing digital image data corresponding to the received X-rays is provided. The digital image capturer includes a light generator for receiving the X-rays and for emitting light in response to the received X-rays; a first planar reflector for reflecting the emitted light; a second planar reflector positioned for receiving the emitted light from the first planar reflector, and reflecting the emitted light; and, a fast relay-optics system for receiving the emitted light from the second planar reflector and for focusing the emitted light onto a digital imaging device. The digital imaging device generates the digital image data.
Patent NZ-563445-A (NZ)
Title: Gel compositions for control of ecto-parasites
Inventor: FATTOHI NAHLA
Filed: 2006-05-19
Abstract: Disclosed is a composition formulated for topical administration which comprises on a weight to weight basis from about 5% to about 30% of metaflumizone; from about 1% to about 15% of a gelling agent; from about 0% to about 8% of a surfactant; and from about 45% to about 80% of a non-aqueous solvent system.
Patent NZ-573247-A (NZ)
Title: Activating carbon material using an arc to heat to a specific temperature
Inventor: ABRAHAMSON JOHN
IPC: B01J19/08
Filed: 2008-11-28
Abstract: Disclosed is a method for producing an activated carbon material. The method includes: within a reaction chamber (1) causing relative movement between a carbon-containing substrate (8) and an electric arc in a gap between two electrodes (2, 3) or adjacent an electrode. The movement is done so that an electric arc exists between the electrode and the substrate to heat the substrate to a substrate surface temperature, the temperature effective to activate the carbon-containing substrate and above about 3750K.
Patent NZ-577385-A (NZ)
Title: Multi-component filter comprising a segment having at least one flavour bearing thread and a segment having flavour bearing cellulosic particles
Inventor: BESSO CLEMENT
IPC: A24D3/04
Filed: 2008-03-20
Abstract: A multi-component filter (4) for a cigarette (10) is disclosed. The filter (4) comprises a first (12) and second (14) flavour releasing segments. The first segment (12) comprises at least one flavour-bearing thread (16) and the second segment (14) comprises flavour bearing cellulosic particles (18). Such configuration allows the smoke to be flavoured when drawn from a rod (2) through the filter (4).